Department of Nephrology, Antwerp University Hospital, Edegem, Belgium.
Department of Medical Informatics, ERA-EDTA Registry, Amsterdam UMC, Academic Medical Center, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
Nephrol Dial Transplant. 2021 Apr 26;36(5):918-926. doi: 10.1093/ndt/gfab024.
Changes in recipient and donor factors have reopened the question of survival benefits of kidney transplantation versus dialysis.
We analysed survival among 3808 adult Belgian patients waitlisted for a first deceased donor kidney transplant from 2000 to 2012. The primary outcome was mortality during the median waiting time plus 3 years of follow-up after transplantation or with continued dialysis. Outcomes were analysed separately for standard criteria donor (SCD) and expanded criteria donor (ECD) kidney transplants. We adjusted survival analyses for recipient age (20-44, 45-64 and ≥65 years), sex and diabetes as the primary renal disease.
Among patients ≥65 years of age, only SCD transplantation provided a significant survival benefit compared with dialysis, with a mortality of 16.3% [95% confidence interval (CI) 13.2-19.9] with SCD transplantation, 20.5% (95% CI 16.1-24.6) with ECD transplantation and 24.6% (95% CI 19.4-29.5) with continued dialysis. Relative mortality risk was increased in the first months after transplantation compared with dialysis, with equivalent risk levels reached earlier with SCD than ECD transplantation in all age groups.
The results of this study suggest that older patients might gain a survival benefit with SCD transplantation versus dialysis, but any survival benefit with ECD transplantation versus dialysis may be small.
受体和供体因素的变化重新引发了关于肾移植与透析的生存获益问题。
我们分析了 2000 年至 2012 年期间,3808 名等待首次已故供体肾移植的成年比利时患者的生存情况。主要结局是移植后中位等待时间加 3 年随访期间或继续透析期间的死亡率。分别对标准标准供体(SCD)和扩展标准供体(ECD)肾移植的结果进行了分析。我们调整了生存分析,以纳入受体年龄(20-44、45-64 和≥65 岁)、性别和糖尿病作为主要肾脏疾病。
在≥65 岁的患者中,只有 SCD 移植与透析相比提供了显著的生存获益,SCD 移植的死亡率为 16.3%(95%CI 13.2-19.9),ECD 移植的死亡率为 20.5%(95%CI 16.1-24.6),继续透析的死亡率为 24.6%(95%CI 19.4-29.5)。与透析相比,移植后最初几个月的相对死亡率增加,在所有年龄组中,SCD 比 ECD 更早达到与透析相当的风险水平。
本研究结果表明,与透析相比,SCD 移植可能使老年患者获得生存获益,但 ECD 移植与透析相比的任何生存获益可能都很小。